Literature DB >> 17075389

Beyond the checklist: assessing understanding for HIV vaccine trial participation in South Africa.

Graham Lindegger1, Cecilia Milford, Catherine Slack, Michael Quayle, Xolani Xaba, Eftyhia Vardas.   

Abstract

OBJECTIVES: Informed consent and understanding are essential ethical requirements for clinical trial participation. Traditional binary measures of understanding may be limited and not be the best measures of level of understanding. This study designed and compared 4 measures of understanding for potential participants being prepared for enrollment in South African HIV vaccine trials, using detailed operational scoring criteria.
METHODS: Assessment of understanding of 7 key trial components was compared via self-report, checklist, vignettes, and narrative measures. Fifty-nine participants, including members of vaccine preparedness groups and 1 HIV vaccine trial, took part.
RESULTS: There were significant differences across the measures for understanding of 5 components and for overall understanding. Highest scores were obtained on self-report and checklist measures, and lowest scores were obtained for vignettes and narrative descriptions.
CONCLUSIONS: The findings suggest that levels of measured understanding are dependent on the tools used. Forced-choice measures like checklists tend to yield higher scores than open-ended measures like narratives or vignettes. Consideration should be given to complementing checklists and self-reports with open-ended measures, particularly for critical trial concepts, where the consequences of misunderstanding are potentially severe.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17075389     DOI: 10.1097/01.qai.0000247225.37752.f5

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  34 in total

1.  "Once Bitten, Twice Shy": participant perspectives in the aftermath of an early HIV vaccine trial termination.

Authors:  P A Newman; S Yim; A Daley; R Walisser; R Halpenny; W Cunningham; M Loutfy
Journal:  Vaccine       Date:  2010-11-12       Impact factor: 3.641

2.  Tailoring information provision and consent processes to research contexts: the value of rapid assessments.

Authors:  Susan Bull; Bobbie Farsides; Fasil Tekola Ayele
Journal:  J Empir Res Hum Res Ethics       Date:  2012-02       Impact factor: 1.742

3.  Theoretical model of critical issues in informed consent in HIV vaccine trials.

Authors:  Cindi A Lewis; Stephen Dewhurst; James M McMahon; Catherine A Bunce; Michael C Keefer; Amina P Alio
Journal:  AIDS Care       Date:  2014-05-28

4.  Measuring the process and quality of informed consent for clinical research: development and testing.

Authors:  Elizabeth Gross Cohn; Haomiao Jia; Winifred Chapman Smith; Katherine Erwin; Elaine L Larson
Journal:  Oncol Nurs Forum       Date:  2011-07       Impact factor: 2.172

5.  Convergent ethical issues in HIV/AIDS, tuberculosis and malaria vaccine trials in Africa: Report from the WHO/UNAIDS African AIDS Vaccine Programme's Ethics, Law and Human Rights Collaborating Centre consultation, 10-11 February 2009, Durban, South Africa.

Authors:  Nicole Mamotte; Douglas Wassenaar; Jennifer Koen; Zaynab Essack
Journal:  BMC Med Ethics       Date:  2010-03-09       Impact factor: 2.652

6.  Expectation of volunteers towards the vaccine efficacy of the prime-boost HIV vaccine phase III trial during unblinding.

Authors:  Kessuda Khowsroy; Jittima Dhitavat; Yupa Sabmee; Pataramon Laowarakul; Jutarat Wattanakitwichai; Jiraporn Auetian; Kannika Lothong; Roongtip Boondao; Sarawan Maythaarttaphong; Sunee Yaemwong; Jean-Louis Excler; Supachai Rerks-Ngarm; Punnee Pitisuttithum
Journal:  AIDS Res Hum Retroviruses       Date:  2014-07-08       Impact factor: 2.205

7.  Conceptual framework for behavioral and social science in HIV vaccine clinical research.

Authors:  Chuen-Yen Lau; Edith M Swann; Sagri Singh; Zuhayr Kafaar; Helen I Meissner; James P Stansbury
Journal:  Vaccine       Date:  2011-08-05       Impact factor: 3.641

8.  The Significance of Benefit Perceptions for the Ethics of HIV Research Involving Adolescents in Kenya.

Authors:  Stuart Rennie; Allison K Groves; Denise Dion Hallfors; Bonita J Iritani; Fredrick S Odongo; Winnie K Luseno
Journal:  J Empir Res Hum Res Ethics       Date:  2017-07-21       Impact factor: 1.742

9.  Ancillary care in South African HIV vaccine trials: addressing needs, drafting protocols, and engaging community.

Authors:  Catherine M Slack
Journal:  J Empir Res Hum Res Ethics       Date:  2014-02       Impact factor: 1.742

10.  Taking social relationships seriously: lessons learned from the informed consent practices of a vaccine trial on the Kenyan Coast.

Authors:  Caroline Gikonyo; Philip Bejon; Vicki Marsh; Sassy Molyneux
Journal:  Soc Sci Med       Date:  2008-03-24       Impact factor: 4.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.